The drug discovery and development industry demands scientific rigour, strict regulation, and interdisciplinary expertise. This field unites molecular biology, chemistry, pharmacology, toxicology, bioinformatics, clinical medicine, regulatory science, manufacturing, and commercialisation. Due to this complexity, training and education are essential for industry success.
With rapid scientific innovation and evolving regulatory expectations, the industry relies on continuous professional development, interdisciplinary education, and workforce upskilling. Forward-thinking organisations understand that training is now essential throughout the professional lifecycle, from academic preparation to lifelong learning. This article encourages academics and industry leaders to recognise and strengthen the role, structure, and future direction of training and education in drug discovery and development to gain a competitive advantage.
Drug Discovery and Development
Drug discovery and development is a multistage process, each with specific training requirements. Drug discovery involves target identification, hit discovery, and lead optimisation. Preclinical development covers pharmacokinetics, pharmacodynamics, toxicology, safety assessment, and chemistry, manufacturing, and controls (CMC). Clinical development requires expertise in phase I-III trials, biostatistics, data management, clinical operations, and medical monitoring. Careers in manufacturing and commercialisation demand knowledge of Good Manufacturing Practice (GMP), Quality Assurance (QA), and Quality Control (QC). Throughout development, scientists must follow regulatory guidelines for product approval. Early career professionals need to understand applications such as Investigative New Drugs (INDs), New Drug Applications (NDAs), and Marketing Authorisation Applications (MAA) submissions. The process continues after product launch, with lifecycle management and pharmacovigilance essential for patient safety. Each stage requires specialised scientific, regulatory, and operational training, highlighting the need for role-specific education pathways.
Training for Industry
Most professionals enter the industry through formal education in life sciences, pharmacy, medicine, or engineering. Undergraduate and postgraduate programs provide the core scientific knowledge, laboratory and analytical skills, research methodology, and critical thinking capabilities required in the scientific arena. However, academic curricula often provide limited exposure to regulatory science, GMP, and industrial workflows, creating a skills gap when graduates enter industry.
Doctoral and postdoctoral training are essential for innovation-driven roles in discovery and translational research. However, traditional PhD programmes may not fully prepare scientists for industry decision-making, cross-functional collaboration, or regulatory requirements. Many institutions now address this by offering industry placements and professional skills training.
Industry Specific Training
Industry-specific training is the key to bridging the gap between academia and industry. Employers seeking qualified candidates must offer robust, targeted training, as many postgraduates currently lack essential skills for industrial roles. The pharmaceutical sector invests an estimated $2 billion annually in on-the-job training, underscoring its necessity for developing competent professionals in regulated environments. Such training – covering Standard Operating Procedures (SOP), instrument qualification, data integrity, ALCOA+ principles, and health, safety, and biosafety is critical to maintaining consistency, compliance, and inspection readiness. Organisations that prioritise these efforts are best positioned to succeed.
